1. The legacy of ZikaPLAN
- Author
-
Annelies Wilder-Smith, Elizabeth B. Brickley, Ricardo Arraes de Alencar Ximenes, Demócrito de Barros Miranda-Filho, Celina Maria Turchi Martelli, Tom Solomon, Bart C. Jacobs, Carlos A. Pardo, Lyda Osorio, Beatriz Parra, Suzannah Lant, Hugh J Willison, Sonja Leonhard, Lance Turtle, Maria Lúcia Brito Ferreira, Rafael Freitas de Oliveira Franca, Louis Lambrechts, Johan Neyts, Suzanne Kaptein, Rosanna Peeling, Deborah Boeras, James Logan, Helen Dolk, Ieda M Orioli, Andreas Neumayr, Trudie Lang, Bonny Baker, Eduardo Massad, Raman Preet, Umeå University, University of Heidelberg, Medical Faculty, London School of Hygiene and Tropical Medicine (LSHTM), Universidade Federal de Pernambuco [Recife] (UFPE), Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP), University of Liverpool, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Johns Hopkins University School of Medicine [Baltimore], Universidad del Valle [Cali] (Univalle), University of Glasgow, Erasmus University Rotterdam, Hospital da Restauração, Instituto Oswaldo Cruz / Oswaldo Cruz Institute [Rio de Janeiro] (IOC), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Interactions Virus-Insectes - Insect-Virus Interactions (IVI), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Rega Institute for Medical Research [Leuven, België], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Global Health Impact Group, University of Ulster, Federal University of Rio de Janeiro, Swiss Tropical and Public Health Institute [Basel], University of Oxford, Universidade de São Paulo = University of São Paulo (USP), This project, ZikaPLAN is funded by the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. h2020 health 734584. Some authors have received additional research funding. The Microencephaly Epidemic Research Group (MERG) has received additional funding from Wellcome Trust UK, Department for International Development UK, Medical Research Council UK, the Brazilian funding through CNPq, Secretaria de Vigilância de Saúde (SVS), and Fundação do Amparo a Ciência e Tecnologia (FACEPE). LT is supported by a Wellcome Trust fellowship [205228/Z/16/Z]. The Latin American Congenital Malformations Network (ReLAMC) group has received additional Brazilian funding through DECIT, CNPq (440614/2016-3), and CAPES (88887.130724/2016-00, 88887.130724/2016-00), and European Project: 734584,ZikaPLAN
- Subjects
Adult ,congenital Zika syndrome ,encephalitis ,birth defect ,MESH: Zika Virus ,MESH: Global Health ,research capacity building ,Global Health ,MESH: Zika Virus Infection ,Zika ,epidemic preparedness ,SDG 3 - Good Health and Well-being ,MESH: Child ,Humans ,microcephaly ,European Commission ,Child ,MESH: Humans ,Zika Virus Infection ,Health Policy ,Public Health, Environmental and Occupational Health ,Guillain-Barré Syndrome ,MESH: Adult ,Public Health, Global Health, Social Medicine and Epidemiology ,Zika Virus ,sustainability ,Infectious Disease Transmission, Vertical ,MESH: Infectious Disease Transmission, Vertical ,Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ,[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology ,MESH: Brazil ,Brazil - Abstract
Global health research partnerships with institutions from high-income countries and low- and middle-income countries are one of the European Commission's flagship programmes. Here, we report on the ZikaPLAN research consortium funded by the European Commission with the primary goal of addressing the urgent knowledge gaps related to the Zika epidemic and the secondary goal of building up research capacity and establishing a Latin American-European research network for emerging vector-borne diseases. Five years of collaborative research effort have led to a better understanding of the full clinical spectrum of congenital Zika syndrome in children and the neurological complications of Zika virus infections in adults and helped explore the origins and trajectory of Zika virus transmission. Individual-level data from ZikaPLAN`s cohort studies were shared for joint analyses as part of the Zika Brazilian Cohorts Consortium, the European Commission-funded Zika Cohorts Vertical Transmission Study Group, and the World Health Organization-led Zika Virus Individual Participant Data Consortium. Furthermore, the legacy of ZikaPLAN includes new tools for birth defect surveillance and a Latin American birth defect surveillance network, an enhanced Guillain-Barre Syndrome research collaboration, a de-centralized evaluation platform for diagnostic assays, a global vector control hub, and the REDe network with freely available training resources to enhance global research capacity in vector-borne diseases. ispartof: GLOBAL HEALTH ACTION vol:14 issue:sup1 ispartof: location:United States status: published
- Published
- 2022